A61L31/08

ENERGY DEVICE FOR SURGICAL OPERATIONS

There is provided an energy device for surgical operation capable of suppressing fixation of body tissue, wherein a coating layer is formed on an outer periphery of a base material constituting an operational area portion transmitting energy in an energy device for surgical operation operating in the operational area portion, and is comprised of a base coating formed on the base material and an outermost coating formed on the base coating. The base coating is made from silicon oxide or a compound containing silicon oxide, and the outermost coating is made from polysiloxane or a compound containing polysiloxane or a compound containing a partly fluorinated polysiloxane, and the coating layer has a good adhesiveness and is applicable to a complicated form.

Removable deployment system and method for implantable mesh prostheses

A medical device including a mesh prosthesis having a first mesh layer affixed to a second mesh layer along a perimeter area. An enclosure is defined between the first and second layers and extends inwardly from the perimeter area. An opening in the first layer passes through the first layer to the enclosure. A fixation guide template defines a guide pocket within the enclosure. A resilient deployment structure is removably disposed within the enclosure and extending toward the perimeter area. The resilient deployment structure has an elasticity that generates a resilient deployment force for urging the mesh prosthesis to a deployed configuration from a non-deployed configuration. A shield projection extends outwardly from a perimeter of the resilient deployment structure and is engaged within the guide pocket to prevent relative rotational movement between the resilient deployment structure and the mesh prosthesis. A method of using a medical device is also included.

Removable deployment system and method for implantable mesh prostheses

A medical device including a mesh prosthesis having a first mesh layer affixed to a second mesh layer along a perimeter area. An enclosure is defined between the first and second layers and extends inwardly from the perimeter area. An opening in the first layer passes through the first layer to the enclosure. A fixation guide template defines a guide pocket within the enclosure. A resilient deployment structure is removably disposed within the enclosure and extending toward the perimeter area. The resilient deployment structure has an elasticity that generates a resilient deployment force for urging the mesh prosthesis to a deployed configuration from a non-deployed configuration. A shield projection extends outwardly from a perimeter of the resilient deployment structure and is engaged within the guide pocket to prevent relative rotational movement between the resilient deployment structure and the mesh prosthesis. A method of using a medical device is also included.

Coatings for the controllable release of antimicrobial metal ions

Antimicrobial metal ion coatings. In particular, described herein are coatings including an anodic metal (e.g., silver and/or zinc and/or copper) that is co-deposited with a cathodic metal (e.g., palladium, platinum, gold, molybdenum, titanium, iridium, osmium, niobium or rhenium) on a substrate so that the anodic metal is galvanically released as antimicrobial ions when the apparatus is exposed to a bodily fluid. The anodic metal may be at least about 25 percent by volume of the coating, resulting in a network of anodic metal with less than 20% of the anodic metal in the coating fully encapsulated by cathodic metal.

PROCESS FOR FORMING A THERMALLY AND CHEMICALLY INERT MULTILAYER FILM
20170290958 · 2017-10-12 ·

A process for forming a thermally and chemically inert multi-layer film on a substrate, comprising depositing a composition comprising one or more inorganic oxide material, or mixtures thereof, on the substrate such as to form a continuous layer comprising a at least partially fused inorganic oxide material; depositing a composition comprising one or more non-fluorinated silane compounds, or mixtures thereof, on the continuous layer comprising a fused inorganic oxide material such as to form a layer comprising non-fluorinated polysiloxane; depositing a composition comprising one or more fluorinated silane compounds on the layer comprising non-fluorinated polysiloxane such as to form a layer comprising fluorinated silanes bearing a fluorinated group; depositing a composition comprising one or more copolymers of tetrafluoroethylene on the layer comprising fluorinated silanes bearing a fluorinated group such as to form a layer comprising a copolymer of tetrafluoroethylene.

CO-CRYSTALS, METHOD AND APPARATUS FOR FORMING THE SAME
20220048911 · 2022-02-17 ·

Disclosed herein is a method and apparatus for synthesizing co-crystals from the vapor phase without the need for liquid solvent. Also disclosed herein are co-crystals formed from the vapor phase, substrates coated with said co-crystals, pharmaceutical compositions thereof and apparatuses for producing said co-crystals.

CO-CRYSTALS, METHOD AND APPARATUS FOR FORMING THE SAME
20220048911 · 2022-02-17 ·

Disclosed herein is a method and apparatus for synthesizing co-crystals from the vapor phase without the need for liquid solvent. Also disclosed herein are co-crystals formed from the vapor phase, substrates coated with said co-crystals, pharmaceutical compositions thereof and apparatuses for producing said co-crystals.

Stents having controlled elution

Provided herein is a drug delivery system comprising: a. substrate; b. a plurality of components combined with the substrate to form the drug delivery system; wherein at least one components comprises a bioabsorbable polymer and at least one other component comprises one or more active agents; wherein at least part of the active agent is in crystalline form.

Stents having controlled elution

Provided herein is a drug delivery system comprising: a. substrate; b. a plurality of components combined with the substrate to form the drug delivery system; wherein at least one components comprises a bioabsorbable polymer and at least one other component comprises one or more active agents; wherein at least part of the active agent is in crystalline form.

SKIN TAG REMOVER
20170273705 · 2017-09-28 ·

The present invention is a skin tag remover which includes a cord formed into a loop at a tag end for placing around a skin tag, a cord housing for receiving a portion of the cord there through and a finger ring attached to a ring end of the cord. Pulling on the finger ring tightens the loop around the skin tag and places the cord into a constricted position so that blood flow is restricted to the skin tag. A blade is included in the cord housing with a plunger that urges the blade downward to sever and detach the cord from the cord housing.